Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g
- Available purity: >97%
- Inventory rows with stock: 4
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 5021-45-4
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
| 1g |
>97% |
1
In Stock
|
Hong Kong |
Inquiry |
| 5g |
>97% |
1
In Stock
|
Beijing |
Inquiry |
5021-45-4 / 2-(4-bromophenyl)quinoxaline
Standard CAS: 5021-45-4
Multi CAS: Yes
Basic Information
CAS
5021-45-4
Multi CAS
Yes
Molecular Formula
BC14H9Rn2
Molecular Weight
285.140000
Exact Mass
283.994910
InChI
InChI=1S/C14H9BrN2/c15-11-7-5-10(6-8-11)14-9-16-12-3-1-2-4-13(12)17-14/h1-9H
InChIKey
FXKZRBJBUFVFNR-UHFFFAOYSA-N
Computed Properties
Structural Parameters
Heavy atom count
17
Aromatic heavy atom count
16
Rotatable bonds
1
H-bond acceptors
2
Molar refractivity
72.67
TPSA
25.78
LogP / Solubility
WLOGP
4.06
MLOGP
3.58
XLogP3
3.6
Consensus LogP
3.75
Log S (ESOL)
-4.8
Class (ESOL)
Slightly soluble
Log S (Ali)
-4.83
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-5
Class (SILICOS-IT)
Slightly soluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
No
Log Kp (skin permeation)
-1.58
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
No
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
1.5